Europe Tumor Ablation Market By Treatment (Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation) By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer) By Country, Industry Analysis and Forecast, 2019 - 2025
The Europe Tumor Ablation Market would witness market growth of 10% CAGR during the forecast period (2019-2025).
The factors projected to accelerate the demand for advanced tumor ablation technologies over the forecast period include increased inclination of surgeons and patients towards minimally invasive procedures due to benefits such as speedy recovery, patient satisfaction, and lowered turnaround time. Advanced treatments for tumor ablation are generally performed on an outpatient basis and do not involve hospital admission compared to traditional therapies. This also significantly reduces the overall healthcare cost.
One of the facilitating factors of the revolutionary treatment has been the high success rate of tumor ablation, which also makes it one of the most favored tumor therapies where other therapies might not be effective for multiple reasons. The procedure of tumor ablation has been used to treat different types of cancer such as colorectal cancer, lung cancer, liver cancer, prostate cancer, etc.
The ongoing technological advancements have made tumor ablation treatment a safe and painless one especially due to impressive results during and after the procedure. With increasing awareness in the healthcare industry around the world, cancer ablation is becoming increasingly popular for different types of cancer as one of the most favored cancer therapy methods. Hospitals and healthcare centers are recognizing the immense potential of cancer ablation therapy, thereby supporting their patients with the facility that would further assist in facilitating the therapeutic.
Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Scope of the Study
Market Segmentation:
By Treatment
The factors projected to accelerate the demand for advanced tumor ablation technologies over the forecast period include increased inclination of surgeons and patients towards minimally invasive procedures due to benefits such as speedy recovery, patient satisfaction, and lowered turnaround time. Advanced treatments for tumor ablation are generally performed on an outpatient basis and do not involve hospital admission compared to traditional therapies. This also significantly reduces the overall healthcare cost.
One of the facilitating factors of the revolutionary treatment has been the high success rate of tumor ablation, which also makes it one of the most favored tumor therapies where other therapies might not be effective for multiple reasons. The procedure of tumor ablation has been used to treat different types of cancer such as colorectal cancer, lung cancer, liver cancer, prostate cancer, etc.
The ongoing technological advancements have made tumor ablation treatment a safe and painless one especially due to impressive results during and after the procedure. With increasing awareness in the healthcare industry around the world, cancer ablation is becoming increasingly popular for different types of cancer as one of the most favored cancer therapy methods. Hospitals and healthcare centers are recognizing the immense potential of cancer ablation therapy, thereby supporting their patients with the facility that would further assist in facilitating the therapeutic.
Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Scope of the Study
Market Segmentation:
By Treatment
- Surgical Ablation
- Laparoscopic Ablation and
- Percutaneous Ablation
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Irreversible Electroporation and
- Other Technology
- Liver Cancer
- Breast Cancer
- Lung Cancer
- Kidney Cancer
- Prostate Cancer and
- Other Cancer
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Medtronic PLC
- Johnson and Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Misonix, Inc.
- EDAP TMS S.A.
- Theraclion SA
- AngioDynamics, Inc.
- Mermaid Medical A/S
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
- SonaCare Medical, LLC
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Tumor Ablation Market, by Treatment
1.4.2 Europe Tumor Ablation Market, by Technology
1.4.3 Europe Tumor Ablation Market, by Application
1.4.4 Europe Tumor Ablation Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: Jan 2016 - Oct 2019) Leading Players
CHAPTER 4. EUROPE TUMOR ABLATION MARKET BY TREATMENT
4.1 Europe Surgical Ablation Market by Country
4.2 Europe Laparoscopic Ablation Market by Country
4.3 Europe Percutaneous Ablation Market by Country
CHAPTER 5. EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY
5.1 Europe Radiofrequency Ablation Market by Country
5.2 Europe Microwave Ablation Market by Country
5.3 Europe Cryoablation Market by Country
5.4 Europe Irreversible Electroporation Market by Country
5.5 Europe Other Technology Market by Country
CHAPTER 6. EUROPE TUMOR ABLATION MARKET BY APPLICATION
6.1 Europe Liver Cancer Market by Country
6.2 Europe Breast Cancer Market by Country
6.3 Europe Lung Cancer Market by Country
6.4 Europe Kidney Cancer Market by Country
6.5 Europe Prostate Cancer Market by Country
6.6 Europe Others Cancer Market by Country
CHAPTER 7. EUROPE TUMOR ABLATION MARKET BY COUNTRY
7.1 Germany Tumor Ablation Market
7.1.1 Germany Tumor Ablation Market by Treatment
7.1.2 Germany Tumor Ablation Market by Technology
7.1.3 Germany Tumor Ablation Market by Application
7.2 UK Tumor Ablation Market
7.2.1 UK Tumor Ablation Market by Treatment
7.2.2 UK Tumor Ablation Market by Technology
7.2.3 UK Tumor Ablation Market by Application
7.3 France Tumor Ablation Market
7.3.1 France Tumor Ablation Market by Treatment
7.3.2 France Tumor Ablation Market by Technology
7.3.3 France Tumor Ablation Market by Application
7.4 Russia Tumor Ablation Market
7.4.1 Russia Tumor Ablation Market by Treatment
7.4.2 Russia Tumor Ablation Market by Technology
7.4.3 Russia Tumor Ablation Market by Application
7.5 Spain Tumor Ablation Market
7.5.1 Spain Tumor Ablation Market by Treatment
7.5.2 Spain Tumor Ablation Market by Technology
7.5.3 Spain Tumor Ablation Market by Application
7.6 Italy Tumor Ablation Market
7.6.1 Italy Tumor Ablation Market by Treatment
7.6.2 Italy Tumor Ablation Market by Technology
7.6.3 Italy Tumor Ablation Market by Application
7.7 Rest of Europe Tumor Ablation Market
7.7.1 Rest of Europe Tumor Ablation Market by Treatment
7.7.2 Rest of Europe Tumor Ablation Market by Technology
7.7.3 Rest of Europe Tumor Ablation Market by Application
CHAPTER 8. COMPANY PROFILES
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 Johnson and Johnson (Ethicon, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.1 Recent strategies and developments:
8.2.1.1 Acquisition and Mergers:
8.2.1.2 Product Launches and Product Expansions:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Misonix, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 EDAP TMS S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Theraclion SA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.7 AngioDynamics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Mermaid Medical A/S
8.8.1 Company Overview
8.9 HealthTronics, Inc. (Altaris Capital Partners, LLC)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.9.2.2 Partnerships, Collaborations, and Agreements:
8.1 SonaCare Medical, LLC
8.10.1 Company overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Tumor Ablation Market, by Treatment
1.4.2 Europe Tumor Ablation Market, by Technology
1.4.3 Europe Tumor Ablation Market, by Application
1.4.4 Europe Tumor Ablation Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: Jan 2016 - Oct 2019) Leading Players
CHAPTER 4. EUROPE TUMOR ABLATION MARKET BY TREATMENT
4.1 Europe Surgical Ablation Market by Country
4.2 Europe Laparoscopic Ablation Market by Country
4.3 Europe Percutaneous Ablation Market by Country
CHAPTER 5. EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY
5.1 Europe Radiofrequency Ablation Market by Country
5.2 Europe Microwave Ablation Market by Country
5.3 Europe Cryoablation Market by Country
5.4 Europe Irreversible Electroporation Market by Country
5.5 Europe Other Technology Market by Country
CHAPTER 6. EUROPE TUMOR ABLATION MARKET BY APPLICATION
6.1 Europe Liver Cancer Market by Country
6.2 Europe Breast Cancer Market by Country
6.3 Europe Lung Cancer Market by Country
6.4 Europe Kidney Cancer Market by Country
6.5 Europe Prostate Cancer Market by Country
6.6 Europe Others Cancer Market by Country
CHAPTER 7. EUROPE TUMOR ABLATION MARKET BY COUNTRY
7.1 Germany Tumor Ablation Market
7.1.1 Germany Tumor Ablation Market by Treatment
7.1.2 Germany Tumor Ablation Market by Technology
7.1.3 Germany Tumor Ablation Market by Application
7.2 UK Tumor Ablation Market
7.2.1 UK Tumor Ablation Market by Treatment
7.2.2 UK Tumor Ablation Market by Technology
7.2.3 UK Tumor Ablation Market by Application
7.3 France Tumor Ablation Market
7.3.1 France Tumor Ablation Market by Treatment
7.3.2 France Tumor Ablation Market by Technology
7.3.3 France Tumor Ablation Market by Application
7.4 Russia Tumor Ablation Market
7.4.1 Russia Tumor Ablation Market by Treatment
7.4.2 Russia Tumor Ablation Market by Technology
7.4.3 Russia Tumor Ablation Market by Application
7.5 Spain Tumor Ablation Market
7.5.1 Spain Tumor Ablation Market by Treatment
7.5.2 Spain Tumor Ablation Market by Technology
7.5.3 Spain Tumor Ablation Market by Application
7.6 Italy Tumor Ablation Market
7.6.1 Italy Tumor Ablation Market by Treatment
7.6.2 Italy Tumor Ablation Market by Technology
7.6.3 Italy Tumor Ablation Market by Application
7.7 Rest of Europe Tumor Ablation Market
7.7.1 Rest of Europe Tumor Ablation Market by Treatment
7.7.2 Rest of Europe Tumor Ablation Market by Technology
7.7.3 Rest of Europe Tumor Ablation Market by Application
CHAPTER 8. COMPANY PROFILES
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 Johnson and Johnson (Ethicon, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.1 Recent strategies and developments:
8.2.1.1 Acquisition and Mergers:
8.2.1.2 Product Launches and Product Expansions:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Misonix, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 EDAP TMS S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Theraclion SA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.7 AngioDynamics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Mermaid Medical A/S
8.8.1 Company Overview
8.9 HealthTronics, Inc. (Altaris Capital Partners, LLC)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.9.2.2 Partnerships, Collaborations, and Agreements:
8.1 SonaCare Medical, LLC
8.10.1 Company overview
LIST OF TABLES
TABLE 1 EUROPE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– TUMOR ABLATION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– TUMOR ABLATION MARKET
TABLE 5 MERGERS & ACQUISITIONS – TUMOR ABLATION MARKET
TABLE 6 EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 7 EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 8 EUROPE SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 9 EUROPE SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 10 EUROPE LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 11 EUROPE LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 12 EUROPE PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 13 EUROPE PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 14 EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 15 EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 16 EUROPE RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 17 EUROPE RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 18 EUROPE MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 19 EUROPE MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 20 EUROPE CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 21 EUROPE CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 22 EUROPE IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 23 EUROPE IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 24 EUROPE OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 25 EUROPE OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 26 EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 27 EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 28 EUROPE LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 29 EUROPE LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 30 EUROPE BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 31 EUROPE BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 32 EUROPE LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 33 EUROPE LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 34 EUROPE KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 35 EUROPE KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 36 EUROPE PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 37 EUROPE PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 38 EUROPE OTHERS CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 39 EUROPE OTHERS CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 40 EUROPE TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 41 EUROPE TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 42 GERMANY TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 43 GERMANY TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 44 GERMANY TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 45 GERMANY TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 46 GERMANY TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 47 GERMANY TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 48 GERMANY TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 49 GERMANY TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 50 UK TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 51 UK TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 52 UK TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 53 UK TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 54 UK TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 55 UK TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 56 UK TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 57 UK TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 58 FRANCE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 59 FRANCE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 60 FRANCE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 61 FRANCE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 62 FRANCE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 63 FRANCE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 64 FRANCE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 65 FRANCE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 66 RUSSIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 67 RUSSIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 68 RUSSIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 69 RUSSIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 70 RUSSIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 71 RUSSIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 72 RUSSIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 73 RUSSIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 74 SPAIN TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 75 SPAIN TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 76 SPAIN TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 77 SPAIN TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 78 SPAIN TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 79 SPAIN TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 80 SPAIN TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 81 SPAIN TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 82 ITALY TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 83 ITALY TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 84 ITALY TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 85 ITALY TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 86 ITALY TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 87 ITALY TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 88 ITALY TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 89 ITALY TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 90 REST OF EUROPE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 91 REST OF EUROPE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 92 REST OF EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 93 REST OF EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 94 REST OF EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 95 REST OF EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 96 REST OF EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 97 REST OF EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 98 KEY INFORMATION – MEDTRONIC PLC
TABLE 99 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 100 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 101 KEY INFORMATION – MISONIX, INC.
TABLE 102 KEY INFORMATION – EDAP TMS S.A.
TABLE 103 KEY INFORMATION – THERACLION SA
TABLE 104 KEY INFORMATION – ANGIODYNAMICS, INC.
TABLE 105 KEY INFORMATION – MERMAID MEDICAL A/S
TABLE 106 KEY INFORMATION – HEALTHTRONICS, INC.
TABLE 107 KEY INFORMATION – SONACARE MEDICAL, LLC
TABLE 1 EUROPE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– TUMOR ABLATION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– TUMOR ABLATION MARKET
TABLE 5 MERGERS & ACQUISITIONS – TUMOR ABLATION MARKET
TABLE 6 EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 7 EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 8 EUROPE SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 9 EUROPE SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 10 EUROPE LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 11 EUROPE LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 12 EUROPE PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 13 EUROPE PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 14 EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 15 EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 16 EUROPE RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 17 EUROPE RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 18 EUROPE MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 19 EUROPE MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 20 EUROPE CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 21 EUROPE CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 22 EUROPE IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 23 EUROPE IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 24 EUROPE OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 25 EUROPE OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 26 EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 27 EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 28 EUROPE LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 29 EUROPE LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 30 EUROPE BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 31 EUROPE BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 32 EUROPE LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 33 EUROPE LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 34 EUROPE KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 35 EUROPE KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 36 EUROPE PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 37 EUROPE PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 38 EUROPE OTHERS CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 39 EUROPE OTHERS CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 40 EUROPE TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 41 EUROPE TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 42 GERMANY TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 43 GERMANY TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 44 GERMANY TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 45 GERMANY TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 46 GERMANY TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 47 GERMANY TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 48 GERMANY TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 49 GERMANY TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 50 UK TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 51 UK TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 52 UK TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 53 UK TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 54 UK TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 55 UK TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 56 UK TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 57 UK TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 58 FRANCE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 59 FRANCE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 60 FRANCE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 61 FRANCE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 62 FRANCE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 63 FRANCE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 64 FRANCE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 65 FRANCE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 66 RUSSIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 67 RUSSIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 68 RUSSIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 69 RUSSIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 70 RUSSIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 71 RUSSIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 72 RUSSIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 73 RUSSIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 74 SPAIN TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 75 SPAIN TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 76 SPAIN TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 77 SPAIN TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 78 SPAIN TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 79 SPAIN TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 80 SPAIN TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 81 SPAIN TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 82 ITALY TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 83 ITALY TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 84 ITALY TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 85 ITALY TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 86 ITALY TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 87 ITALY TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 88 ITALY TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 89 ITALY TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 90 REST OF EUROPE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 91 REST OF EUROPE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 92 REST OF EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 93 REST OF EUROPE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 94 REST OF EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 95 REST OF EUROPE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 96 REST OF EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 97 REST OF EUROPE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 98 KEY INFORMATION – MEDTRONIC PLC
TABLE 99 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 100 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 101 KEY INFORMATION – MISONIX, INC.
TABLE 102 KEY INFORMATION – EDAP TMS S.A.
TABLE 103 KEY INFORMATION – THERACLION SA
TABLE 104 KEY INFORMATION – ANGIODYNAMICS, INC.
TABLE 105 KEY INFORMATION – MERMAID MEDICAL A/S
TABLE 106 KEY INFORMATION – HEALTHTRONICS, INC.
TABLE 107 KEY INFORMATION – SONACARE MEDICAL, LLC
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: JAN 2016 - OCT 2019) LEADING PLAYERS
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: JAN 2016 - OCT 2019) LEADING PLAYERS
